1. Home
  2. BHVN vs ATRC Comparison

BHVN vs ATRC Comparison

Compare BHVN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$14.34

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$48.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
ATRC
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2022
2005

Fundamental Metrics

Financial Performance
Metric
BHVN
ATRC
Price
$14.34
$48.52
Analyst Decision
Buy
Strong Buy
Analyst Count
14
7
Target Price
$29.08
$51.17
AVG Volume (30 Days)
1.9M
780.7K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
26.08
74.74
EPS
N/A
0.18
Revenue
N/A
$201,630,000.00
Revenue This Year
N/A
$15.27
Revenue Next Year
N/A
$12.21
P/E Ratio
N/A
$273.78
Revenue Growth
N/A
15.40
52 Week Low
$7.48
$25.36
52 Week High
$18.57
$49.88

Technical Indicators

Market Signals
Indicator
BHVN
ATRC
Relative Strength Index (RSI) 48.79 79.77
Support Level $13.84 $26.47
Resistance Level $15.04 N/A
Average True Range (ATR) 0.66 1.61
MACD -0.06 0.37
Stochastic Oscillator 42.13 89.12

Price Performance

Historical Comparison
BHVN
ATRC

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: